User: TahirAmin Topic: IP
Category: patent-legal-regime :: india
Last updated: Feb 12 2016 22:32 IST RSS 2.0
 
1 to 20 of 3,067    
CBI registers case against NIPER officials 12.2.2016 TOI: India
A case of alleged corruption has been registered by CBI against officials of National Institute of Pharmaceutical Education and Research (NIPER) and a private company in the purchase of licenses for accessing a global patent database software causing losses of Rs 10 ...
Also found in: [+]
US Chamber says India's patent protection not of global standards 10.2.2016 Deccan Herald - Business
The US Chamber of Commerce on Wednesday released its 4th Annual International IP Index 'Infinite Possibilities'. It measures the Intellectual Property environment in 38 economies, including India, which ranked No 37. While the index found that India's score was largely unchanged, patent protection in India remains outside of international best practices, it said. Indian law does not provide adequate enforcement mechanisms to effectively combat online piracy, it added. The index, produced by the chamber's Global Intellectual Property Center (GIPC), places the United States in lead position, while Venezuela has finished last. Overall, half of the 38 economies improved their total score from last year's index, indicating increased recognition of the benefits of intellectual property (IP) and a strong IP system. The economies benchmarked in the 2016 index account for nearly 85 per cent of the global GDP. The index is based on 30 measurable criteria critical to innovation including, patent, copyright and ...
Also found in: [+]
US chamber ranks India second-last in IP Index 10.2.2016 All News-IANS Stories
Suggesting that patent protection in India remains outside of international best practice, the US Chamber of Commerce has ranked the country second-last in an International Index of Intellectual Property (IP) environment in 38 economies.
Also found in: [+]
US chamber ranks India second-last in IP Index 10.2.2016 New Kerala: World News
Washington, Feb 10 : Suggesting that patent protection in India remains outside of international best practice, the US Chamber of Commerce has ranked the country second-last in an International Index of Intellectual Property (IP) environment in 38 economies.
Also found in: [+]
India ranks very low in global patent index: study 10.2.2016 New Kerala: Business India
Bengaluru, Feb 10 : India is ranked 37th or second last in the international IP (intellectual property) index by the US Chamber of Commerce, it was announced on Wednesday.
Also found in: [+]
India ranks very low in global patent index: study 10.2.2016 All News-IANS Stories
India is ranked 37th or second last in the international IP (intellectual property) index by the US Chamber of Commerce, it was announced on Wednesday.
Also found in: [+]
India ranks second-last in US Chamber's international IP index 10.2.2016 Latest News
Patent protection in India is nowhere near best practices globally, and law doesn't provide adequate enforcement mechanisms to combat online piracy, the report said
Also found in: [+]
India ranked 2nd last in US IP index rankings 10.2.2016 FirstPost: Business

India has ranked second last in new US Chamber International IP Index rankings, largely unchanged from the last year's, said a press release from the chamber. The index, produced by the Chamber’s Global Intellectual Property Center (GIPC), measured the IP environment in India alongside 37 other economies. Patent protection in India remains outside of international […]

The post India ranked 2nd last in US IP index rankings appeared first on Firstpost.

Also found in: [+]
US pharma body slams Indian patent regime 9.2.2016 TOI: India Business
Criticizing India’s “weak” intellectual property rights (IPR) regime, PhRMA (Pharmaceutical Research and Manufacturers of America), which represents leading pharma and biotech companies in the US, has suggested India remain on the Priority Watch List in the 2016 Special 301 Report.
Also found in: [+]
Seminar discusses Biological Diversity Act and its flaws 7.2.2016 TOI: Cities
Cell for awareness and research in environmental law studies (CARES), National Law Institute University, Bhopal, in collaboration with Madhya Pradesh state biodiversity board organized BIOSANCTUM 2016-a national seminar on Biological Diversity Act, 2002 and ABS Regulations, 2014 on ...
Also found in: [+]
The pill that costs $9,000 in US sells for $70 in India 7.2.2016 ET: Pharma
Typically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the US.
Also found in: [+]
The pill that costs $9,000 in US sells for $70 in India 6.2.2016 TOI: Sunday
The Hyderabad-based Bharat Biotech might be the first to come out with a vaccine for the Zika virus if its efficacy can be ...
Also found in: [+]
Compulsory licensing in manufacturing may slow investments: EU 5.2.2016 Hindu: Home
The U.S. had also sought clarity from India regarding the CL decision-making process
Also found in: [+]
Ill-equipped and exorbitant: India’s fight against cancer is a horror for its patients 4.2.2016 FirstPost: India

The distance we need to travel before cancer treatment is universally available is clear from the fact that cancer surveillance is in its infancy.

The post Ill-equipped and exorbitant: India’s fight against cancer is a horror for its patients appeared first on Firstpost.

Also found in: [+]
World Cancer Day: Compulsory licensing of key drugs only way for India to fight this grave threat 4.2.2016 FirstPost: Life

About four years ago, cancer usually meant a slow death, coupled with a vain fight, for the common man. It was largely because of the exorbitant costs of medicines.

The post World Cancer Day: Compulsory licensing of key drugs only way for India to fight this grave threat appeared first on Firstpost.

Also found in: [+]
RBI to create enabling framework for growth of start-ups 2.2.2016 FirstPost: Business

The Reserve Bank today said it will take steps to help improve the 'ease of doing business' in the country and contribute to an ecosystem that is conducive for the growth of start-up businesses.

The post RBI to create enabling framework for growth of start-ups appeared first on Firstpost.

Also found in: [+]
Licensing policy needed on critical medicine: Y.K. Hamied  28.1.2016 HBL: Home
The Government needs to frame guidelines to facilitate licensing arrangements between companies to bring critical drugs into the country, says Cipla Chairman Dr Y K Hamied.   “We have to de...
Also found in: [+]
SC agrees to hear Cipla’s plea against La Roche 28.1.2016 TOI: India Business
The Supreme Court on Wednesday admitted a plea of generic drug manufacturer Cipla Ltd challenging the Delhi high court order holding it guilty of infringing Swiss pharma company Hoffmann-La Roche’s patent over lung cancer drug Erlotinib.
Also found in: [+]
Supreme Court agrees to hear Cipla’s plea against La Roche 27.1.2016 TOI: All Headlines
Supreme Court agrees to hear Cipla’s plea against La Roche
Also found in: [+]
Supreme Court agrees to hear Cipla’s plea against La Roche 27.1.2016 TOI: India
The Supreme Court on Wednesday admitted a plea of generic drug manufacturer Cipla Ltd challenging Delhi high court order holding it guilty of infringing Swiss pharma company Hoffmann-La Roche. Roche’s patent over lung cancer drug ...
Also found in: [+]
1 to 20 of 3,067